Tag: Rich Levy

November 9, 2015 Off

Investigational baricitinib superior to methotrexate monotherapy in achveing clinical remission

Eli Lilly and Company and Incyte Corporation have announced detailed data from the pivotal phase 3 RA-BEGIN study, which show…

October 14, 2015 Off

Eli Lilly and Company and Incyte Corporation: Positive Topline Results of RA-BEAM

By Dino Mustafić

Eli Lilly and Company and Incyte Corporation announced positive topline results of RA-BEAM, the fourth successful Phase 3 study of baricitinib, an investigational medicine for patients with moderately-to-severely active rheumatoid arthritis.